Dawei Chen
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
- Biomaterials 102
- Nanoparticle-Based Drug Delivery 100
-
- Advanced Drug Delivery Systems 25
- Drug Solubulity and Delivery Systems 14
- Co-authors
- Haiyang Hu (102 shared papers)Mingxi Qiao (77 shared papers)Xiuli Zhao (73 shared papers)Jiulong Zhang (26 shared papers)Lifang Cheng (12 shared papers)Jing Qin (3 shared papers)Lipeng Qiu (11 shared papers)Yifan Luo (1 shared paper)
- Journals
- International Journal of Pharmaceutics (15 papers)Acta Biomaterialia (13 papers)Journal of Controlled Release (11 papers)International Journal of Nanomedicine (10 papers)ACS Applied Materials & Interfaces (8 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dawei Chen
216 papers receiving 8k citations
Peers
Comparison fields: 5 of 120
- Biomaterials 3.2k
- Pharmaceutical Science 1.5k
- Drug Discovery 49
- Molecular Medicine 404
- Oncology 567
Countries citing papers authored by Dawei Chen
This map shows the geographic impact of Dawei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Chen more than expected).
Fields of papers citing papers by Dawei Chen
This network shows the impact of papers produced by Dawei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Chen. The network helps show where Dawei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 353 | |
| 2 | 2017 | 254 | |
| 3 | 2005 | 246 | |
| 4 | 2013 | 168 | |
| 5 | 2019 | 168 | |
| 6 | 2006 | 150 | |
| 7 | 2014 | 145 | |
| 8 | 2013 | 127 | |
| 9 | 2016 | 126 | |
| 10 | 2019 | 113 | |
| 11 | 2002 | 110 | |
| 12 | 2017 | 105 | |
| 13 | 2014 | 102 | |
| 14 | 2019 | 99 | |
| 15 | 2008 | 98 | |
| 16 | 2013 | 98 | |
| 17 | 2014 | 96 | |
| 18 | 2012 | 93 | |
| 19 | 2015 | 93 | |
| 20 | 2007 | 92 |
About Dawei Chen
Dawei Chen is a scholar working on Biomaterials, Pharmaceutical Science, Oncology, Polymers and Plastics and Biomedical Engineering, having authored 219 papers that have together received 8.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (100 papers), RNA Interference and Gene Delivery (28 papers), Advanced Drug Delivery Systems (25 papers), Nanoplatforms for cancer theranostics (24 papers), Cancer Immunotherapy and Biomarkers (14 papers), Drug Solubulity and Delivery Systems (14 papers), Dendrimers and Hyperbranched Polymers (13 papers) and Hydrogels: synthesis, properties, applications (7 papers). The work is most often cited by research in Biomaterials (3.2k citations), Pharmaceutical Science (1.5k citations), Drug Discovery (49 citations), Molecular Medicine (404 citations) and Oncology (567 citations). Dawei Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Haiyang Hu, Mingxi Qiao, Xiuli Zhao, Jiulong Zhang, Lifang Cheng, Jing Qin, Lipeng Qiu, Yifan Luo, Lixiang Ren and Xinlong Zang. Their work appears in journals such as International Journal of Pharmaceutics, Acta Biomaterialia, Journal of Controlled Release, International Journal of Nanomedicine and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.